Search

Your search keyword '"Federica, Bellone"' showing total 77 results

Search Constraints

Start Over You searched for: Author "Federica, Bellone" Remove constraint Author: "Federica, Bellone"
77 results on '"Federica, Bellone"'

Search Results

1. Psychological impairment in inflammatory bowel diseases: the key role of coping and defense mechanisms

2. Ketoacidosis and SGLT2 Inhibitors: A Narrative Review

3. Interrelations between clinical-psychological features and bone mineral density changes in post-menopausal women undergoing anti-osteoporotic treatment: a two-year follow-up

4. Trabecular bone score and phalangeal quantitative ultrasound are associated with muscle strength and fracture risk in hemodialysis patients

5. Efficacy and Safety of Biological Therapies and JAK Inhibitors in Older Patients with Inflammatory Bowel Disease

6. Nutraceuticals as Alternative Approach against Cadmium-Induced Kidney Damage: A Narrative Review

7. Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D

9. Trabecular bone score, bone marrow fat and vertebral fractures in cushing syndrome

10. Alexithymia and Inflammatory Bowel Disease: A Systematic Review

11. Going Beyond the Visible in Type 2 Diabetes Mellitus: Defense Mechanisms and Their Associations With Depression and Health-Related Quality of Life

12. Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer.

13. Alexithymia and Psychological Distress Affect Perceived Quality of Life in Patients with Type 2 Diabetes Mellitus

14. Quality of Life (QoL) in Patients with Chronic Inflammatory Bowel Diseases: How Much Better with Biological Drugs?

15. Executive functions and bone health: a focus on cognitive impulsivity and bone mineral density

16. As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration

20. Vitamin D, Bone Metabolism, and Fracture Risk in Polycystic Ovary Syndrome

21. Changes in Cognitive and Functional Status and in Quality of Life of Older Outpatients during the COVID-19 Pandemic

23. Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients

24. Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both

25. Hyponatremia as a leading sign of hypopituitarism

26. Quality of life in postmenopausal women: which role for vitamin D?

27. Vitamin D status is associated with anxiety levels in postmenopausal women evaluated for osteoporosis

28. Psychological factors may impacton postmenopausal women fracture risk

29. Rates of hypomagnesemia and hypermagnesemia in medical settings

30. Haemophilia and Fragility Fractures: From Pathogenesis to Multidisciplinary Approach

31. Association between cognitive reserve dimensions and frailty among older adults: A structured narrative review

32. The association between hypoparathyroidism and cognitive impairment: a systematic review

33. Impact of Diabetes Mellitus and Its Comorbidities on Elderly Patients Hospitalized in Internal Medicine Wards: Data from the RePoSi Registry

34. Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates

35. Relation between drug therapy-based comorbidity indices, Charlson's comorbidity index, polypharmacy and mortality in three samples of older adults

38. Kidney Disease Management in the Hospital Setting: A Focus on Inappropriate Drug Prescriptions in Older Patients

39. Anxiety Levels Predict Bone Mineral Density in Postmenopausal Women Undergoing Oral Bisphosphonates: A Two-Year Follow-Up

40. Zoledronic Acid Induces Early Changes of VEGF Levels in Women With Postmenopausal Osteoporosis

41. Fatigue, sarcopenia, and frailty in older adults with Inflammatory Bowel Disease

42. Vitamin D Boosts Alendronate Tail Effect on Bone Mineral Density in Postmenopausal Women with Osteoporosis

43. Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates

44. Early Changes of VEGF Levels After Zoledronic Acid in Women With Postmenopausal Osteoporosis: A Potential Role of Vitamin D

45. Renal Function, Cardiovascular Diseases, Appropriateness of Drug Prescription and Outcomes in Hospitalized Older Patients

46. Initiation of Psycholeptic Medication During Hospitalization With Recommendation for Discontinuation After Discharge

47. POS1119 A SINGLE DOSE OF ZOLEDRONATE INDUCES MODIFICATIONS OF SERUM VEGF IN OSTEOPOROTIC POSTMENOPAUSAL WOMEN

48. Use of Lipid-Lowering Drugs and Associated Outcomes According to Health State Profiles in Hospitalized Older Patients

49. Comparison between drug therapy-based comorbidity indices and the Charlson Comorbidity Index for the detection of severe multimorbidity in older subjects

50. Vitamin D, Bone Metabolism, and Fracture Risk in Polycystic Ovary Syndrome

Catalog

Books, media, physical & digital resources